Published on 21 Aug 2023 on Zacks via Yahoo Finance
In the past six months, InflaRx’s IFRX shares have surged 110.1% against the industry’s 7.2% fall.
Image Source: Zacks Investment Research
Start tracking your investments with Statfolio
InflaRx N.V. (IFRX) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus ...
Key Insights Significant control over InflaRx by individual investors implies that the general pu...
InflaRx N.V. (IFRX) has been beaten down lately with too much selling pressure. While the stock h...
InflaRx N.V. (IFRX) witnesses a hammer chart pattern, indicating support found by the stock after...
In this piece, we will take a look at the 12 best German stocks to buy now. If you want to skip o...
It was a busy week for the biotech sector, with quite a few important regulatory and pipeline upd...
In the past six months, InflaRx’s IFRX shares have surged 110.1% against the industry’s 7.2% fall...
Key Insights InflaRx's significant retail investors ownership suggests that the key decisions are...
InflaRx N.V. (NASDAQ:IFRX) is possibly approaching a major achievement in its business, so we wou...